Aroon Supramaniam

449 total citations
15 papers, 310 citations indexed

About

Aroon Supramaniam is a scholar working on Infectious Diseases, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Aroon Supramaniam has authored 15 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 7 papers in Molecular Biology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Aroon Supramaniam's work include SARS-CoV-2 and COVID-19 Research (8 papers), RNA Interference and Gene Delivery (5 papers) and Viral Infections and Vectors (4 papers). Aroon Supramaniam is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (8 papers), RNA Interference and Gene Delivery (5 papers) and Viral Infections and Vectors (4 papers). Aroon Supramaniam collaborates with scholars based in Australia, United States and Türkiye. Aroon Supramaniam's co-authors include Adi Idris, Nigel A.J. McMillan, Gabrielle Kelly, Kevin V. Morris, Roslyn M. Ray, Dhruba Acharya, Yaman Tayyar, Lara J. Herrero, Christopher L. D. McMillan and Tristan Scott and has published in prestigious journals such as PLoS ONE, Antimicrobial Agents and Chemotherapy and Science Advances.

In The Last Decade

Aroon Supramaniam

15 papers receiving 309 citations

Peers

Aroon Supramaniam

IMMUN

PHEOH

GENET

Maria T. Arévalo United States

Elise Larson United States

Emily Bettini United States

Alireza Masoudi Iran

Janet R. Phelps United States

Ho Him Wong Hong Kong

Gabrielle Kelly Australia

Justine S. McPartlan United States

Keyvan Tadjalli Mehr Germany

Krunal Polra United Kingdom

Maria T. Arévalo United States

Aroon Supramaniam

104 ×0.6

99 ×0.6

72 ×1.6

IMMUN

58 ×1.9

PHEOH

34 ×1.3

GENET

Citations per year, relative to Aroon Supramaniam Aroon Supramaniam (= 1×) peers Maria T. Arévalo

Countries citing papers authored by Aroon Supramaniam

Since Specialization

Citations

This map shows the geographic impact of Aroon Supramaniam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aroon Supramaniam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aroon Supramaniam more than expected).

Fields of papers citing papers by Aroon Supramaniam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aroon Supramaniam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aroon Supramaniam. The network helps show where Aroon Supramaniam may publish in the future.

Co-authorship network of co-authors of Aroon Supramaniam

This figure shows the co-authorship network connecting the top 25 collaborators of Aroon Supramaniam. A scholar is included among the top collaborators of Aroon Supramaniam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aroon Supramaniam. Aroon Supramaniam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Idris, Adi, Wenqing Gao, Aroon Supramaniam, et al.. (2025). Intranasal delivery of engineered anti-SARS-CoV-2 extracellular vesicles therapeutically represses lung infection and inflammation. Drug Delivery and Translational Research. 15(11). 4115–4125. 1 indexed citations

Idris, Adi, Aroon Supramaniam, Yaman Tayyar, et al.. (2024). An intranasally delivered ultra-conserved siRNA prophylactically represses SARS-CoV-2 infection in the lung and nasal cavity.. Antiviral Research. 222. 105815–105815. 11 indexed citations

Idris, Adi, Aroon Supramaniam, Roslyn M. Ray, et al.. (2024). Extracellular Vesicles Loaded with Long Antisense RNAs Repress Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Nucleic Acid Therapeutics. 34(3). 101–108. 3 indexed citations

Kayabölen, Alişan, et al.. (2024). ACE2-Decorated Virus-Like Particles Effectively Block SARS-CoV-2 Infection. International Journal of Nanomedicine. Volume 19. 6931–6943. 2 indexed citations

Supramaniam, Aroon, Yaman Tayyar, Daniel Clarke, et al.. (2023). Prophylactic intranasal administration of lipid nanoparticle formulated siRNAs reduce SARS-CoV-2 and RSV lung infection. Journal of Microbiology Immunology and Infection. 56(3). 516–525. 16 indexed citations

Isaacs, Ariel, Alberto A. Amarilla, Julio Aguado, et al.. (2022). Nucleocapsid Specific Diagnostics for the Detection of Divergent SARS-CoV-2 Variants. Frontiers in Immunology. 13. 926262–926262. 10 indexed citations

Scott, Tristan, Aroon Supramaniam, Adi Idris, et al.. (2022). Engineered extracellular vesicles directed to the spike protein inhibit SARS-CoV-2. Molecular Therapy — Methods & Clinical Development. 24. 355–366. 33 indexed citations

McMillan, Christopher L. D., Adi Idris, Aroon Supramaniam, et al.. (2021). Complete protection by a single-dose skin patch–delivered SARS-CoV-2 spike vaccine. Science Advances. 7(44). eabj8065–eabj8065. 32 indexed citations

Idris, Adi, Aroon Supramaniam, Dhruba Acharya, et al.. (2021). A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19. Molecular Therapy. 29(7). 2219–2226. 125 indexed citations

10.

Supramaniam, Aroon, et al.. (2021). RNA-based gene targeting therapies for human papillomavirus driven cancers. Cancer Letters. 523. 111–120. 11 indexed citations

11.

Supramaniam, Aroon, Helle Bielefeldt‐Ohmann, Penny A. Rudd, et al.. (2019). PG545 treatment reduces RRV-induced elevations of AST, ALT with secondary lymphoid organ alterations in C57BL/6 mice. PLoS ONE. 14(6). e0217998–e0217998. 4 indexed citations

12.

Lim, Elisa X. Y., Aroon Supramaniam, Hayman Lui, et al.. (2018). Chondrocytes Contribute to Alphaviral Disease Pathogenesis as a Source of Virus Replication and Soluble Factor Production. Viruses. 10(2). 86–86. 9 indexed citations

13.

Supramaniam, Aroon, Xiang Liu, Vito Ferro, & Lara J. Herrero. (2018). Prophylactic Antiheparanase Activity by PG545 Is Antiviral In Vitro and Protects against Ross River Virus Disease in Mice. Antimicrobial Agents and Chemotherapy. 62(4). 22 indexed citations

14.

Supramaniam, Aroon, Hayman Lui, Bernadette Bellette, Penny A. Rudd, & Lara J. Herrero. (2018). How myeloid cells contribute to the pathogenesis of prominent emerging zoonotic diseases. Journal of General Virology. 99(8). 953–969. 11 indexed citations

15.

Nelson, Michelle, Lara J. Herrero, J. Jeffery, et al.. (2016). Role of envelope N-linked glycosylation in Ross River virus virulence and transmission. Journal of General Virology. 97(5). 1094–1106. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact